|
1
|
International Diabetes Federation (IDF).
IDF Diabetes Atlas (7th). 2017.
|
|
2
|
Edwards JL, Vincent AM, Cheng HT and
Feldman EL: Diabetic neuropathy: Mechanisms to management.
Pharmacol Ther. 120:1–34. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harati Y: Diabetic neuropathies:
Unanswered questions. Neurol Clin. 25:303–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Farmer KL, Li C and Dobrowsky RT: Diabetic
peripheral neuropathy: Should a chaperone accompany our therapeutic
approach? Pharmacol Rev. 64:880–900. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spallone V, Lacerenza M, Rossi A, Sicuteri
R and Marchettini P: Painful diabetic polyneuropathy: Approach to
diagnosis and management. Clin J Pain. 28:726–743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Snyder MJ, Gibbs LM and Lindsay TJ:
Treating painful diabetic peripheral neuropathy: An update. Am Fam
Physician. 94:227–234. 2016.PubMed/NCBI
|
|
7
|
Schreiber AK, Nones CF, Reis RC, Chichorro
JG and Cunha JM: Diabetic neuropathic pain: Physiopathology and
treatment. World J Diabetes. 6:432–444. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tesfaye S, Vileikyte L, Rayman G, Sindrup
SH, Perkins BA, Baconja M, Vinik AI and Boulton AJ: Toronto Expert
Panel on Diabetic Neuropathy: Painful diabetic peripheral
neuropathy: Consensus recommendations on diagnosis, assessment and
management. Diabetes Metab Res Rev. 27:629–638. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jane SW, Lin MS, Chiu WN, Beaton RD and
Chen MY: Prevalence, discomfort and self-relief behaviours of
painful diabetic neuropathy in Taiwan: A cross-sectional study. BMJ
Open. 6:e118972016. View Article : Google Scholar
|
|
10
|
Tesfaye S, Boulton AJ and Dickenson AH:
Mechanisms and management of diabetic painful distal symmetrical
polyneuropathy. Diabetes Care. 36:2456–2465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gore M, Brandenburg NA, Dukes E, Hoffman
DL, Tai KS and Stacey B: Pain severity in diabetic peripheral
neuropathy is associated with patient functioning, symptom levels
of anxiety and depression, and sleep. J Pain Symptom Manage.
30:374–385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vileikyte L, Leventhal H, Gonzalez JS,
Peyrot M, Rubin RR, Ulbrecht JS, Garrow A, Waterman C, Cavanagh PR
and Boulton AJ: Diabetic peripheral neuropathy and depressive
symptoms: The association revisited. Diabetes Care. 28:2378–2383.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sadosky A, McDermott AM, Brandenburg NA
and Strauss M: A review of the epidemiology of painful diabetic
peripheral neuropathy, postherpetic neuralgia, and less commonly
studied neuropathic pain conditions. Pain Pract. 8:45–56. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ziegler D: Painful diabetic neuropathy:
Treatment and future aspects. Diabetes Metab Res Rev. 24 Suppl
1:S52–S57. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kaku M, Vinik A and Simpson DM: Pathways
in the diagnosis and management of diabetic polyneuropathy. Curr
Diab Rep. 15:6092015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sawynok J and Zinger C: Topical
amitriptyline and ketamine for post-herpetic neuralgia and other
forms of neuropathic pain. Expert Opin Pharmacother. 17:601–609.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ziegler D and Fonseca V: From guideline to
patient: A review of recent recommendations for pharmacotherapy of
painful diabetic neuropathy. J Diabetes Complications. 29:146–156.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Nooten F, Treur M, Pantiri K, Stoker M
and Charokopou M: Capsaicin 8% patch versus oral neuropathic pain
medications for the treatment of painful diabetic peripheral
neuropathy: A systematic literature review and network
meta-analysis. Clin Ther. 39:787–803.e18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Argoff CE: Topical analgesics in the
management of acute and chronic pain. Mayo Clin Proc. 88:195–205.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jorge LL, Feres CC and Teles VE: Topical
preparations for pain relief: Efficacy and patient adherence. J
Pain Res. 4:11–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Derry S, Rice AS, Cole P, Tan T and Moore
RA: Topical capsaicin (high concentration) for chronic neuropathic
pain in adults. Cochrane Database Syst Rev.
1:CD0073932017.PubMed/NCBI
|
|
22
|
Mick G and Correa-Illanes G: Topical pain
management with the 5% lidocaine medicated plaster-a review. Curr
Med Res Opin. 28:937–951. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mou J, Paillard F, Turnbull B, Trudeau J,
Stoker M and Katz NP: Qutenza (capsaicin) 8% patch onset and
duration of response and effects of multiple treatments in
neuropathic pain patients. Clin J Pain. 30:286–294. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kiani J, Ahmad Nasrollahi S, Esna-Ashari
F, Fallah P and Sajedi F: Amitriptyline 2% cream vs. capsaicin
0.75% cream in the treatment of painful diabetic neuropathy (Double
blind, randomized clinical trial of efficacy and safety). Iran J
Pharm Res. 14:1263–1268. 2015.PubMed/NCBI
|
|
25
|
Wrzosek A, Woron J, Dobrogowski J,
Jakowicka-Wordliczek J and Wordliczek J: Topical clonidine for
neuropathic pain. Cochrane Database Syst Rev.
8:CD0109672015.PubMed/NCBI
|
|
26
|
Motilal S and Maharaj RG: Nutmeg extracts
for painful diabetic neuropathy: A randomized, double-blind,
controlled study. J Altern Complement Med. 19:347–352. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Heydari M, Homayouni K, Hashempur MH and
Shams M: Topical Citrullus colocynthis (bitter apple) extract oil
in painful diabetic neuropathy: A double-blind randomized
placebo-controlled clinical trial. J Diabetes. 8:246–252. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
A study of the efficacy and safety of
amitriptyline/ketamine topical cream in patients with diabetic
peripheral neuropathy. simpleClinicalTrials.govNCT00476151. 2006
|
|
29
|
Casale R, Symeonidou Z and Bartolo M:
Topical treatments for localized neuropathic pain. Curr Pain
Headache Rep. 21:152017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sloan G, Shillo P, Selvarajah D, Wu J,
Wilkinson ID, Tracey I, Anand P and Tesfaye S: A new look at
painful diabetic neuropathy. Diabetes Res Clin Pract. 144:177–191.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dewanjee S, Das S, Das AK, Bhattacharjee
N, Dihingia A, Dua TK, Kalita J and Manna P: Molecular mechanism of
diabetic neuropathy and its pharmacotherapeutic targets. Eur J
Pharmacol. 833:472–523. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dobretsov M, Hastings SL, Romanovsky D,
Stimers JR and Zhang JM: Mechanical hyperalgesia in rat models of
systemic and local hyperglycemia. Brain Res. 960:174–183. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oyibo SO, Prasad YD, Jackson NJ, Jude EB
and Boulton AJ: The relationship between blood glucose excursions
and painful diabetic peripheral neuropathy: A pilot study. Diabet
Med. 19:870–873. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Morley GK, Mooradian AD, Levine AS and
Morley JE: Mechanism of pain in diabetic peripheral neuropathy.
Effect of glucose on pain perception in humans. Am J Med. 77:79–82.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee JH, Cox DJ, Mook DG and McCarty RC:
Effect of hyperglycemia on pain threshold in alloxan-diabetic rats.
Pain. 40:105–107. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dyck PJ, Litchy WJ, Lehman KA, Hokanson
JL, Low PA and O'Brien PC: Variables influencing neuropathic
endpoints: The rochester diabetic neuropathy study of healthy
subjects. Neurology. 45:1115–1121. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Romanovsky D, Wang J, Al-Chaer ED, Stimers
JR and Dobretsov M: Comparison of metabolic and neuropathy profiles
of rats with streptozotocin-induced overt and moderate
insulinopenia. Neuroscience. 170:337–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peppa M, Stavroulakis P and Raptis SA:
Advanced glycoxidation products and impaired diabetic wound
healing. Wound Repair Regen. 17:461–472. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Babizhayev MA, Strokov IA, Nosikov VV,
Savel'Yeva EL, Sitnikov VF, Yegorov YE and Lankin VZ: The role of
oxidative stress in diabetic neuropathy: Generation of free radical
species in the glycation reaction and gene polymorphisms encoding
antioxidant enzymes to genetic susceptibility to diabetic
neuropathy in population of type i diabetic patients. Cell Biochem
Biophys. 71:1425–1443. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Oates PJ: Polyol pathway and diabetic
peripheral neuropathy. Int Rev Neurobiol. 50:325–392. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Obrosova IG: How does glucose generate
oxidative stress in peripheral nerve Int Rev Neurobiol. 50:3–35.
2002.PubMed/NCBI
|
|
42
|
Obrosova IG: Diabetes and the peripheral
nerve. Biochim Biophys Acta. 1792:931–940. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Schemmel KE, Padiyara RS and D'Souza JJ:
Aldose reductase inhibitors in the treatment of diabetic peripheral
neuropathy: A review. J Diabetes Complications. 24:354–360. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fuchs D, Birklein F, Reeh PW and Sauer SK:
Sensitized peripheral nociception in experimental diabetes of the
rat. Pain. 151:496–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bachewal P, Gundu C, Yerra VG, Kalvala AK,
Areti A and Kumar A: Morin exerts neuroprotection via attenuation
of ROS induced oxidative damage and neuroinflammation in
experimental diabetic neuropathy. Biofactors. 44:109–122. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tobon-Velasco JC, Cuevas E and
Torres-Ramos MA: Receptor for AGEs (RAGE) as mediator of NF-kB
pathway activation in neuroinflammation and oxidative stress. CNS
Neurol Disord Drug Targets. 13:1615–1626. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gao X, Wu B, Fu Z, Zhang Z and Xu G:
Carvedilol abrogates hypoxia-induced oxidative stress and
neuroinflammation in microglial BV2 cells. Eur J Pharmacol.
814:144–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dworkin RH: An overview of neuropathic
pain: Syndromes, symptoms, signs, and several mechanisms. Clin J
Pain. 18:343–349. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Djouhri L, Fang X, Koutsikou S and Lawson
SN: Partial nerve injury induces electrophysiological changes in
conducting (uninjured) nociceptive and nonnociceptive DRG neurons:
Possible relationships to aspects of peripheral neuropathic pain
and paresthesias. Pain. 153:1824–1836. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Aslam A, Singh J and Rajbhandari S:
Pathogenesis of painful diabetic neuropathy. Pain Res Treat.
2014:4120412014.PubMed/NCBI
|
|
51
|
Rahman MH, Jha MK and Suk K: Evolving
insights into the pathophysiology of diabetic neuropathy:
Implications of malfunctioning glia and discovery of novel
therapeutic targets. Curr Pharm Des. 22:738–757. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Baron R, Mayoral V, Leijon G, Binder A,
Steigerwald I and Serpell M: 5% lidocaine medicated plaster versus
pregabalin in post-herpetic neuralgia and diabetic polyneuropathy:
An open-label, non-inferiority two-stage RCT study. Curr Med Res
Opin. 25:1663–1676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Krumova EK, Zeller M, Westermann A and
Maier C: Lidocaine patch (5%) produces a selective, but incomplete
block of Aδ and C fibers. Pain. 153:273–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Herrmann DN, Barbano RL, Hart-Gouleau S,
Pennella-Vaughan J and Dworkin RH: An open-label study of the
lidocaine patch 5% in painful idiopathic sensory polyneuropathy.
Pain Med. 6:379–384. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Argoff CE, Galer BS, Jensen MP, Oleka N
and Gammaitoni AR: Effectiveness of the lidocaine patch 5% on pain
qualities in three chronic pain states: Assessment with the
neuropathic pain scale. Curr Med Res Opin. 20 Suppl 2:S21–S28.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Barbano RL, Herrmann DN, Hart-Gouleau S,
Pennella-Vaughan J, Lodewick PA and Dworkin RH: Effectiveness,
tolerability, and impact on quality of life of the 5% lidocaine
patch in diabetic polyneuropathy. Arch Neurol. 61:914–918. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Devers A and Galer BS: Topical lidocaine
patch relieves a variety of neuropathic pain conditions: An
open-label study. Clin J Pain. 16:205–208. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wolff RF, Bala MM, Westwood M, Kessels AG
and Kleijnen J: 5% lidocaine medicated plaster in painful diabetic
peripheral neuropathy (DPN): A systematic review. Swiss Med Wkly.
140:297–306. 2010.PubMed/NCBI
|
|
59
|
Baron R, Mayoral V, Leijon G, Binder A,
Steigerwald I and Serpell M: Efficacy and safety of 5% lidocaine
(lignocaine) medicated plaster in comparison with pregabalin in
patients with postherpetic neuralgia and diabetic polyneuropathy:
Interim analysis from an open-label, two-stage adaptive,
randomized, controlled trial. Clin Drug Investig. 29:231–241. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Baron R, Mayoral V, Leijon G, Binder A,
Steigerwald I and Serpell M: Efficacy and safety of combination
therapy with 5% lidocaine medicated plaster and pregabalin in
post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res
Opin. 25:1677–1687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
White WT, Patel N, Drass M and Nalamachu
S: Lidocaine patch 5% with systemic analgesics such as gabapentin:
A rational polypharmacy approach for the treatment of chronic pain.
Pain Med. 4:321–330. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ho KY, Huh BK, White WD, Yeh CC and Miller
EJ: Topical amitriptyline versus lidocaine in the treatment of
neuropathic pain. Clin J Pain. 24:51–55. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zheng J, Zheng S, Feng Q, Zhang Q and Xiao
X: Dietary capsaicin and its anti-obesity potency: From mechanism
to clinical implications. Biosci Rep. 37(pii): BSR20170286.
2017.
|
|
64
|
Musharraf MU, Ahmad Z and Yaqub Z:
Comparison of topical capsaicin and topical turpentine Oil for
treatment of painful diabetic neuropathy. J Ayub Med Coll
Abbottabad. 29:384–387. 2017.PubMed/NCBI
|
|
65
|
Mitchell K, Bates BD, Keller JM, Lopez M,
Scholl L, Navarro J, Madian N, Haspel G, Nemenov MI and Iadarola
MJ: Ablation of rat TRPV1-expressing Adelta/C-fibers with
resiniferatoxin: Analysis of withdrawal behaviors, recovery of
function and molecular correlates. Mol Pain. 6:942010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Fattori V, Hohmann MS, Rossaneis AC,
Pinho-Ribeiro FA and Verri WA: Capsaicin: Current understanding of
its mechanisms and therapy of pain and other pre-clinical and
clinical uses. Molecules. 21(pii): E8442016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
What role for capsaicin in diabetic
peripheral neuropathy? Drug Ther Bull. 54:90–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Rosenberg CJ and Watson JC: Treatment of
painful diabetic peripheral neuropathy. Prosthet Orthot Int.
39:17–28. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Treatment of painful diabetic neuropathy
with topical capsaicin. A multicenter, double-blind,
vehicle-controlled study. The Capsaicin Study Group. Arch Intern
Med. 151:2225–2229. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Effect of treatment with capsaicin on
daily activities of patients with painful diabetic neuropathy. The
Capsaicin Study Group. Diabetes Care. 15:159–165. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Biesbroeck R, Bril V, Hollander P, Kabadi
U, Schwartz S, Singh SP, Ward WK and Bernstein JE: A double-blind
comparison of topical capsaicin and oral amitriptyline in painful
diabetic neuropathy. Adv Ther. 12:111–120. 1995.PubMed/NCBI
|
|
72
|
Tandan R, Lewis GA, Badger GB and Fries
TJ: Topical capsaicin in painful diabetic neuropathy. Effect on
sensory function. Diabetes Care. 15:15–18. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Tandan R, Lewis GA, Krusinski PB, Badger
GB and Fries TJ: Topical capsaicin in painful diabetic neuropathy.
Controlled study with long-term follow-up. Diabetes Care. 15:8–14.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chad DA, Aronin N, Lundstrom R, McKeon P,
Ross D, Molitch M, Schipper HM, Stall G, Dyess E and Tarsy D: Does
capsaicin relieve the pain of diabetic neuropathy? Pain.
42:387–388. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Kulkantrakorn K, Lorsuwansiri C and
Meesawatsom P: 0.025% capsaicin gel for the treatment of painful
diabetic neuropathy: A randomized, double-blind, crossover,
placebo-controlled trial. Pain Pract. 13:497–503. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Simpson DM, Robinson-Papp J, Van J, Stoker
M, Jacobs H, Snijder RJ, Schregardus DS, Long SK, Lambourg B and
Katz N: Capsaicin 8% patch in painful diabetic peripheral
neuropathy: A randomized, double-blind, placebo-controlled study. J
Pain. 18:42–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Vinik AI, Perrot S, Vinik EJ, Pazdera L,
Jacobs H, Stoker M, Long SK, Snijder RJ, van der Stoep M, Ortega E
and Katz N: Capsaicin 8% patch repeat treatment plus standard of
care (SOC) versus SOC alone in painful diabetic peripheral
neuropathy: A randomised, 52-week, open-label, safety study. BMC
Neurol. 16:2512016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Bril V, England J, Franklin GM, Backonja
M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell
JW, et al: Evidence-based guideline: Treatment of painful diabetic
neuropathy: Report of the American academy of neurology, the
American association of neuromuscular and electrodiagnostic
medicine and the American academy of physical medicine and
rehabilitation. PM R. 3:345–352. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Pancrazio JJ, Kamatchi GL, Roscoe AK and
Lynch CR III: Inhibition of neuronal Na+ channels by antidepressant
drugs. J Pharmacol Exp Ther. 284:208–214. 1998.PubMed/NCBI
|
|
80
|
Nicholson GM, Blanche T, Mansfield K and
Tran Y: Differential blockade of neuronal voltage-gated Na(+) and
K(+) channels by antidepressant drugs. Eur J Pharmacol. 452:35–48.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Joshi PG, Singh A and Ravichandra B: High
concentrations of tricyclic antidepressants increase intracellular
Ca2+ in cultured neural cells. Neurochem Res. 24:391–398. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Watson CP: The treatment of neuropathic
pain: Antidepressants and opioids. Clin J Pain. 16 (2
Suppl):S49–S55. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Kopsky DJ and Hesselink JM: High doses of
topical amitriptyline in neuropathic pain: Two cases and literature
review. Pain Pract. 12:148–153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zeraatian S, Zakeri H, Boroojeny SB,
Hourang MH, Ghaffarpasand F and Fard MM: Effect of oral clonidine
on acute intraocular pressure rise after phacoemulsification: A
prospective double-blind, randomized, clinical trial. J Ocul
Pharmacol Ther. 27:293–297. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Otasowie J, Castells X, Ehimare UP and
Smith CH: Tricyclic antidepressants for attention deficit
hyperactivity disorder (ADHD) in children and adolescents. Cochrane
Database Syst Rev. 9:CD0069972014.
|
|
86
|
Sawynok J: Topical analgesics for
neuropathic pain: Preclinical exploration, clinical validation,
future development. Eur J Pain. 18:465–481. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Campbell C, Campbell J, Schmidt W, Brady K
and Stouch B: Topical clonidine gel reduces pain caused by diabetic
neuropathy: Results of a multicenter, placebo-controlled clinical
trial. J Pain. 10 Suppl:S552009. View Article : Google Scholar
|
|
88
|
Campbell CM, Kipnes MS, Stouch BC, Brady
KL, Kelly M, Schmidt WK, Petersen KL, Rowbotham MC and Campbell JN:
Randomized control trial of topical clonidine for treatment of
painful diabetic neuropathy. Pain. 153:1815–1823. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Grover JK, Khandkar S, Vats V, Dhunnoo Y
and Das D: Pharmacological studies on myristica
fragrans-antidiarrheal, hypnotic, analgesic and hemodynamic (blood
pressure) parameters. Methods Find Exp Clin Pharmacol. 24:675–680.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Hayfaa AA, Sahar AM and Awatif MA:
Evaluation of analgesic activity and toxicity of alkaloids in
myristica fragrans seeds in mice. J Pain Res. 6:611–615. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Forouzanfar F and Hosseinzadeh H:
Medicinal herbs in the treatment of neuropathic pain: A review.
Iran J Basic Med Sci. 21:347–358. 2018.PubMed/NCBI
|
|
92
|
Ramanathan T, Gurudeeban S and Satyavani
K: Local anesthetic effect of citrullus colocynthis on rana
hexadactyla. Res J Med Plant. 5:338–342. 2011. View Article : Google Scholar
|
|
93
|
Kumar S, Kumar D, Manjusha, Saroha K,
Singh N and Vashishta B: Antioxidant and free radical scavenging
potential of citrullus colocynthis (L.) schrad. Methanolic fruit
extract. Acta Pharm. 58:215–220. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Reddy VP, Sudheshna G, Shaik A, Saran SS,
Kumar SN, Ram CR and Reddy KR: Evaluation of antiulcer activity of
Citrullus colocynthis fruit against pylorus ligation induced ulcers
in male Wistar rats. Int J Pharm Pharm Sci. 4:446–451. 2012.
|
|
95
|
Nedjat S, Montazeri A, Holakouie K,
Mohammad K and Majdzadeh R: Psychometric properties of the Iranian
interview-administered version of the world health organization's
quality of life questionnaire (WHOQOL-BREF): A population-based
study. BMC Health Serv Res. 8:612008. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Lynch ME, Clark AJ, Sawynok J and Sullivan
MJ: Topical 2% amitriptyline and 1% ketamine in neuropathic pain
syndromes: A randomized, double-blind, placebo-controlled trial.
Anesthesiology. 103:140–146. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Hocking G and Cousins MJ: Ketamine in
chronic pain management: An evidence-based review. Anesth Analg.
97:1730–1739. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Niesters M, Martini C and Dahan A:
Ketamine for chronic pain: Risks and benefits. Br J Clin Pharmacol.
77:357–367. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Mion G and Villevieille T: Ketamine
pharmacology: An update (pharmacodynamics and molecular aspects,
recent findings). Cns Neurosci Ther. 19:370–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Mahoney JM, Vardaxis V, Moore JL, Hall AM,
Haffner KE and Peterson MC: Topical ketamine cream in the treatment
of painful diabetic neuropathy: A randomized, placebo-controlled,
double-blind initial study. J Am Podiatr Med Assoc. 102:178–183.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Lynch ME, Clark AJ and Sawynok J: A pilot
study examining topical amitriptyline, ketamine, and a combination
of both in the treatment of neuropathic pain. Clin J Pain.
19:323–328. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Lynch ME, Clark AJ, Sawynok J and Sullivan
MJ: Topical amitriptyline and ketamine in neuropathic pain
syndromes: An open-label study. J Pain. 6:644–649. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Somberg JC and Molnar J: Retrospective
study on the analgesic activity of a topical (TT-CTAC) cream in
patients with diabetic neuropathy and other chronic pain
conditions. Am J Ther. 22:214–221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Javed S, Petropoulos IN, Alam U and Malik
RA: Treatment of painful diabetic neuropathy. Ther Adv Chronic Dis.
6:15–28. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Stanos SP and Galluzzi KE: Topical
therapies in the management of chronic pain. Postgrad Med. 125 (4
Suppl):S25–S33. 2013. View Article : Google Scholar
|
|
106
|
Barkin RL: The pharmacology of topical
analgesics. Postgrad Med. 125 (4 Suppl 1):S7–S18. 2013. View Article : Google Scholar
|
|
107
|
Pickering G, Martin E, Tiberghien F,
Delorme C and Mick G: Localized neuropathic pain: An expert
consensus on local treatments. Drug Des Devel Ther. 11:2709–2718.
2017. View Article : Google Scholar : PubMed/NCBI
|
